Skip to main navigation
Skip to main content
Soleno Therapeutics Inc. Logo
  • Overview
  • News & Events
    Press Releases In The News Events
  • Presentations
    Investor Presentations Scientific Posters & Presentations
  • Governance
    Governance Highlights Management Board of Directors Committee Composition Contact The Board
  • Financials & Filings
    SEC Filings Annual & Quarterly Results
  • Stock Info
    Stock Quote & Chart Analyst Coverage
  • Contact Us
    IR Contacts Email Alerts RSS Feeds

Investor Relations

Minimum 15 minutes delayed. Source: LSEG

Corporate Profile

Soleno Therapeutics, Inc. (Soleno) is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. 

Latest Quarterly Earnings

Q4 and Annual
2025
  • Press Rlease
  • Form 10-K

View All Earnings

View All Earnings

Press Releases

Feb 26, 2026
Soleno Therapeutics Announces Retirement of James Mackaness and Appointment of Jennifer Fulk as Chief Financial Officer
Feb 25, 2026
Soleno Therapeutics Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides Update on U.S. Launch of VYKAT™ XR
Feb 11, 2026
Soleno Therapeutics to Report Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026, at 4:30 PM ET
View All News

Events

Mar 4, 2026 9:50 AM EST
TD Cowen 46th Annual Health Care Conference
Feb 26, 2026 10:00 AM EST
Oppenheimer 36th Annual Healthcare Life Sciences Conference
Feb 12, 2026 11:30 AM EST
Guggenheim Emerging Outlook: Biotech Summit 2026
View All Events

Presentations

February 2026 Corporate Presentation 1 MB
View All Presentations
Soleno Therapeutics Inc. Logo

Contact Us

100 Marine Parkway
Suite 400
Redwood City, CA 94065
(650) 213-8444
info@soleno.life

  • Terms of Use
  • Privacy Policy
  • © Soleno Therapeutics Inc. 2026